This bill amends VA medical coverage to explicitly include adaptive prostheses and terminal devices designed for sports and recreational activities alongside standard artificial limbs. It directly affects eligible veterans using prosthetic devices who wish to participate in sports or recreational therapy. The key provision expands existing VA coverage under 38 U.S.C. §1701 to cover these specific adaptive devices without requiring separate authorization. This change ensures veterans can access equipment for recreational purposes through the VA's standard medical services. The bill does not create new benefits but clarifies and broadens existing coverage for a defined category of prosthetic devices.
This bill amends the Social Security Act to remove an exclusion for rural facilities primarily treating mental health conditions from Medicare coverage. It specifically changes Section 1861(aa)(2) by deleting the phrase "or a facility which is primarily for the care and treatment of mental diseases," allowing these facilities to qualify for Medicare reimbursement. The change directly affects rural behavioral health centers specializing in mental health care that were previously excluded. The amendment takes effect on January 1, 2027, enabling these facilities to access federal Medicare funding for services.
This bill removes a long-standing federal funding cap that restricted Medicaid spending in U.S. territories. It eliminates the funding limitation (referred to as "Section 1108(f)") for Puerto Rico, the U.S. Virgin Islands, Guam, the Northern Mariana Islands, and American Samoa, effective fiscal year 2025. The key change means these territories will no longer face a cap on federal Medicaid funds, allowing them to access full federal matching dollars for their Medicaid programs. This directly affects the Medicaid programs and residents of these five insular areas by enabling more flexible and potentially expanded coverage.
HR 6255, the Affordable Insulin Now Act, requires health insurance plans (including employer-sponsored and individual plans) to cover specific insulin products starting in 2026. It caps out-of-pocket costs for these insulin products at $35 per 30-day supply or 25% of the negotiated price, whichever is lower, with no deductibles applied. The bill defines "selected insulin products" to include at least one of each dosage form (like vials or pumps) and type (such as rapid-acting or long-acting) available from the plan. This directly affects people with diabetes who rely on insulin, ensuring more predictable and affordable access to essential medications under their health coverage.
This bill requires Medicare to simplify access for family caregivers to beneficiaries' health information. It mandates that Medicare create a new authorization form (CMS-10106) allowing beneficiaries to grant caregivers access to their personal health data via 1-800-MEDICARE. The law also directs Medicare to provide clear outreach through notices, websites, and provider channels, including multilingual materials and training for call center staff. It requires the Secretary to develop fraud protection best practices within one year and ensure all Medicare beneficiaries - regardless of plan type - can authorize caregiver access.
This bill amends the Older Americans Act to integrate "food is medicine" programs into existing nutrition services for older adults. It adds specific references to produce prescriptions, medically tailored meals, and community-based food programs in eligibility screening, caregiver support, and nutrition counseling. The key change requires programs to include referrals to these food-based interventions as part of standard service delivery. This directly affects older Americans receiving nutrition services under the Older Americans Act by expanding available support options through existing federal and community programs.
This bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It defines "pharmacist services" as evaluations and treatments for illnesses like COVID-19, flu, RSV, or strep throat, or services addressing public health emergencies, requiring collaboration with physicians as state law permits. Medicare would pay 80% of the lower of the actual charge or 85% of the physician payment rate (100% for public health emergencies), and prohibits balance billing for these services. The changes take effect January 1, 2026.
This bill redefines certain medical care arrangements for tax purposes. It creates a new category called "direct medical care service arrangements," which are fixed-fee payments (like a monthly subscription) for primary or specialty care directly from doctors, nurse practitioners, or physician assistants - bypassing traditional insurance. These arrangements will no longer be treated as "health plans" under tax law, and their fees will qualify as deductible medical expenses. Employers must also report these fees on employees' W-2 forms. The changes apply to tax years starting after December 2024.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
This bill expands paid leave under the Family and Medical Leave Act (FMLA) to cover "spontaneous loss of an unborn child" (defined as unplanned, non-purposeful loss in the womb), allowing eligible employees to take leave for their own or their spouse's loss. It also creates a new refundable tax credit for individuals who experienced a stillbirth (defined as spontaneous fetal death before delivery), requiring a state-issued stillbirth certificate for eligibility. The bill adds specific certification requirements for leave requests and clarifies how the tax credit integrates with existing tax filing rules. It directly affects private-sector employees covered by FMLA and taxpayers who suffered a stillbirth.
